Clinical meaningfulness of subtle cognitive decline on longitudinal testing in preclinical AD

INTRODUCTION: Demonstrating the “clinical meaningfulness” of slowing early cognitive decline in clinically normal (CN) older adults with elevated amyloid-β (Aβ+) is critical for Alzheimer’s disease (AD) secondary prevention trials and for understanding early cognitive progression. METHODS: Cox regre...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Alzheimers Dement
Main Authors: Papp, Kathryn V., Buckley, Rachel, Mormino, Elizabeth, Maruff, Paul, Villemagne, Victor L., Masters, Colin, Johnson, Keith A., Rentz, Dorene M., Sperling, Reisa A., Amariglio, Rebecca E.
Formato: Artigo
Idioma:Inglês
Publicado em: 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7067681/
https://ncbi.nlm.nih.gov/pubmed/31759879
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jalz.2019.09.074
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados